InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Dahms Bradford D., 首席财务官. Director active across 2 companies, notably Theseus Pharmaceuticals, Inc.. Aggregated, 4 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €27k. History available since 21 December 2021. The latest transaction was filed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Bradford D. Dahms serves as Chief Financial Officer at Theseus Pharmaceuticals, Inc. In this role, he oversees the company's financial operations, including financial planning and reporting. Bradford has significant experience in finance, enabling him to contribute to the company's financial strategy. His analytical approach is essential for navigating a complex financial environment.